Physician profile
David Deer
NPI 1437200482
$202.08
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $49.16 · 2021: $25.42.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $38.51 | 2019 | |
| Progenics Pharmaceuticals, INC. | $25.42 | 2021 | |
| 180 Medical, INC. | $22.15 | 2019 | |
| Abbvie INC. | $18.59 | 2020 | |
| Axonics, INC. | $16.83 | 2020 | |
| Blue Earth Diagnostics | $15.76 | 2019 | |
| Amgen INC. | $15.19 | 2019 | |
| Convatec INC. | $13.74 | 2020 | |
| Therapeuticsmd, INC. | $12.37 | 2019 | |
| Endo Pharmaceuticals INC. | $12.05 | 2019 | |
| Janssen Biotech, INC. | $11.47 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Deer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.